Efficacy of CDK4/6i in preclinical models of malignant pleural mesothelioma
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Assessment of antitumor activity of CDK4/6 inhibitors using in vitro and in vivo preclinical models of MPM using RNA-sequencing. We also include the genomic characterization (whole exome sequencing) of patient-derived cell lines used in the in vitro experiments.EGA study EGAS00001005352
创建时间：
2021-08-24
相关数据集
暂无相关数据集
